Balloon Catheter vs. Basket Catheter for Endoscopic Bile Duct Stone Extraction
Balloon Catheter Versus Basket Catheter for Endoscopic Bile Duct Stone Extraction in Patients With Periampullary Diverticulum:a Multicenter Randomized Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Endoscopic bile duct stone (BDS) removal is a well-established treatment; however, the preference for basket or balloon catheters for extraction is operator-dependent It is reported that complete endoscopic treatment with a single catheter is more likely when choosing a balloon catheter over a basket catheter for extraction of BDSs≤10mm. However, a study comparing the two catheter types in patients with periampullary diverticulum has not been performed, and there is no strong basis on which to recommend the balloon catheter as a first-line stone removal device. The investigators therefore conducted a multicenter prospective randomized trial to compare catheter performance in patients with periampullary diverticulum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 10, 2016
CompletedFirst Posted
Study publicly available on registry
September 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedDecember 14, 2016
September 1, 2016
2 years
September 10, 2016
December 13, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
The primary endpoint is the rate of complete clearance of the duct in two groups.
It has a contrast-injection hole above the balloon for the performance of balloon occlusion cholangiography (BOC). For balloon stone extraction, clearance was confirmed if no residual stones remained after the final BOC and balloon sweep. For basket stone extraction, duct clearance by the basket catheter was judged to have been completed when no filling defect was found. Complete clearance of the duct by the basket catheter was defined as no filling defect (other than air) on BOC after a balloon sweep.
The primary end point was the rate of complete removals of stones within 10 min.
Secondary Outcomes (1)
Secondary endpoints is the rate of adverse events such as perforation, pancreatitis,cholangitis,hyperamylasemia and bleeding.
Secondary endpoints is the rate of adverse events at 24 h after ERCP.
Study Arms (2)
Balloon catheter group
EXPERIMENTALBile duct stones extraction was carried out with a balloon catheter.
Basket catheter group
ACTIVE COMPARATORBile duct stones extraction was carried out with a basket catheter.
Interventions
Balloon stone extraction was carried out with a balloon catheter \[Extractor Pro RX \[M00547000, M00547010, or M00547020\]; Boston Scientific,Shang hai,China). The Extractor Pro has multiple sizes (9-12, 12-15, and 15-18mm), the choice being made on the basis of the CBD diameter. It has a contrast-injection hole above the balloon for the performance of balloon occlusion cholangiography (BOC).
Basket stone extraction was performed with a basket catheter (Flower Basket V \[FG-V435P or FG-V425PR\]; Olympus Corp., Shang hai,China).
Eligibility Criteria
You may qualify if:
- Males and females, age \> 18 years.
- BDSs of diameter ≤10mm, which could be extracted using a standard balloon or basket catheter without mechanical lithotripsy, and a common bile duct (CBD) diameter ≤15mm.
- Signed inform consent form and agreed to follow-up on time
You may not qualify if:
- Medical or psychological condition that would not permit the patient to complete the study or sign the informed consent.
- Patients involved in other study within 60 days.
- biliary stricture
- Billroth II or Roux-en-Y anatomy
- Acute pancreatitis.
- a history of previous ERCP
- pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University
Hefei, Anhui, 230001, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shao Feng, MD
Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University
- PRINCIPAL INVESTIGATOR
Wei Qi, MD
No.2 of HeFei Hospital Affiliated Anhui Medical College
- PRINCIPAL INVESTIGATOR
YongQiang Jiang, MD
Dong fang Hospital Affiliated Anhui University Of Science & Technology
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2016
First Posted
September 21, 2016
Study Start
November 1, 2014
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
December 14, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share